Your browser doesn't support javascript.
loading
Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection.
Jones, Nick K; Rivett, Lucy; Seaman, Shaun; Samworth, Richard J; Warne, Ben; Workman, Chris; Ferris, Mark; Wright, Jo; Quinnell, Natalie; Shaw, Ashley; Goodfellow, Ian G; Lehner, Paul J; Howes, Rob; Wright, Giles; Matheson, Nicholas J; Weekes, Michael P.
Afiliación
  • Jones NK; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Rivett L; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Seaman S; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Samworth RJ; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Warne B; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Workman C; Statistical Laboratory, Centre for Mathematical Sciences, University of Cambridge, Cambridge, United Kingdom.
  • Ferris M; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Wright J; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
  • Quinnell N; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Shaw A; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Goodfellow IG; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Lehner PJ; Occupational Health and Wellbeing, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Howes R; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Wright G; Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Matheson NJ; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Weekes MP; Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
Elife ; 102021 04 08.
Article en En | MEDLINE | ID: mdl-33830018
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido